ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Pulmonary Disease

Top Pulmonary Disease Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GERALD VALLEE M.D.

Pulmonary Disease

10,782

$1.11M

345
316 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 60%

$103
Average prescription price

Avg: $208

WILLIAM KRALL M.D.

Pulmonary Disease

10,134

$789K

545
461 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 60%

$78
Average prescription price

Avg: $208

ARTHUR MOLINOFF MD

Pulmonary Disease

9,741

$747K

296
185 are 65+

18%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 60%

$77
Average prescription price

Avg: $208

DAVID WEINER MD

Pulmonary Disease

7,132

$1.43M

805
662 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 60%

$201
Average prescription price

Avg: $208

FRANCIS LEE MD

Pulmonary Disease

6,875

$1.14M

597
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 60%

$166
Average prescription price

Avg: $208

STEPHEN MOORE MD

Pulmonary Disease

6,716

$431K

297
211 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 60%

$64
Average prescription price

Avg: $208

SIDHAIYAN AIYAPPASAMY MD

Pulmonary Disease

5,815

$398K

92
75 are 65+

14%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 60%

$69
Average prescription price

Avg: $208

ROBERT PICKERING MD

Pulmonary Disease

5,755

$439K

235
178 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 60%

$76
Average prescription price

Avg: $208

TERENCE KILROY MD

Pulmonary Disease

5,702

$881K

423
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 60%

$154
Average prescription price

Avg: $208

JOSEPH THORPE MD

Pulmonary Disease

5,692

$1.16M

658
571 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 60%

$203
Average prescription price

Avg: $208

ROBERT BAUGHMAN M.D.

Pulmonary Disease

5,326

$757K

444
264 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 60%

$142
Average prescription price

Avg: $208

MASROOR MUSTAFA MD

Pulmonary Disease

4,417

$349K

438
352 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 60%

$79
Average prescription price

Avg: $208

THOMAS OLBRYCH MD

Pulmonary Disease

4,384

$1.19M

275
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 60%

$271
Average prescription price

Avg: $208

NAVIN JAIN MD

Pulmonary Disease

4,241

$799K

558
340 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 60%

$188
Average prescription price

Avg: $208

SHAKIL KHAN MD

Pulmonary Disease

4,222

$867K

578
428 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 60%

$205
Average prescription price

Avg: $208

GREGORY COLANGELO M.D.

Pulmonary Disease

4,115

$640K

369
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 60%

$156
Average prescription price

Avg: $208

FELIPE RUBIO MD

Pulmonary Disease

4,075

$618K

454
358 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 60%

$152
Average prescription price

Avg: $208

FRED WAGSHUL MD

Pulmonary Disease

3,962

$616K

386
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 60%

$155
Average prescription price

Avg: $208

KRISTIN HIGHLAND MD

Pulmonary Disease

3,923

$1.91M

180
56 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 60%

$488
Average prescription price

Avg: $208

BRUCE CORSER MD

Pulmonary Disease

3,920

$513K

297
230 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 60%

$131
Average prescription price

Avg: $208

ELIE SAAB MD

Pulmonary Disease

3,782

$1.44M

405
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 60%

$381
Average prescription price

Avg: $208

MARIE BUDEV DO

Pulmonary Disease

3,763

$1.72M

194
81 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 60%

$458
Average prescription price

Avg: $208

RALPH WHITE MD

Pulmonary Disease

3,688

$1.08M

320
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 60%

$292
Average prescription price

Avg: $208

FATEH AHMED MD

Pulmonary Disease

3,672

$648K

486
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 60%

$176
Average prescription price

Avg: $208

RICHARD STERNBERG D.O.

Pulmonary Disease

3,629

$1.08M

330
244 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 60%

$297
Average prescription price

Avg: $208

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank